Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-22 | New | $5,261,533 | $5,261,533 | Equity Only | 06b | SEC link |
| 2022-06-30 | New | $7,033,711 | $7,033,711 | Equity Only | 06b | SEC link |
| 2021-02-03 | New | $3,443,506 | $3,443,506 | Equity Only | 06b | SEC link |
| 2021-01-28 | New | $1,574,163 | $1,574,163 | Debt Only | 06b | SEC link |
| 2018-08-30 | New | $295,000 | $295,000 | Debt Only | 06b | SEC link |
| 2018-01-24 | New | $517,000 | $517,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Michael Bates | Director |
| Robert Bonczek | Director |
| Brent Duncan | Director |
| Ken Gall | Director |
| Robert Isaacs | Director |
| Howard Levinson | Director, Executive |
| Neil Meyer | Director |
| William Perry | Director, Executive |